DENTSPLY SIRONA Inc (NASDAQ:XRAY) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 4,660,000 shares, a drop of 17.8% from the August 15th total of 5,670,000 shares. Currently, 2.1% of the company’s stock are sold short. Based on an average daily volume of 1,660,000 shares, the short-interest ratio is presently 2.8 days.
XRAY has been the topic of a number of recent research reports. Bank of America raised their target price on shares of DENTSPLY SIRONA from $54.00 to $56.00 and gave the stock a “buy” rating in a report on Monday, July 20th. HC Wainwright cut their target price on shares of DENTSPLY SIRONA from $50.00 to $45.00 and set a “neutral” rating on the stock in a report on Monday, August 10th. BidaskClub raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Tuesday. Evercore ISI raised shares of DENTSPLY SIRONA from an “in-line” rating to an “outperform” rating and set a $50.00 target price on the stock in a report on Wednesday, May 27th. Finally, Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating and set a $47.00 price target on the stock in a research note on Monday, August 17th. Ten equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $49.13.
DENTSPLY SIRONA stock opened at $47.39 on Thursday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.38 and a current ratio of 3.10. The firm has a market cap of $10.35 billion, a price-to-earnings ratio of -206.04, a price-to-earnings-growth ratio of 5.06 and a beta of 0.99. DENTSPLY SIRONA has a 1 year low of $31.58 and a 1 year high of $60.87. The firm’s 50 day moving average price is $44.54 and its two-hundred day moving average price is $42.69.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported ($0.18) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.16). The business had revenue of $490.60 million during the quarter, compared to analyst estimates of $492.55 million. DENTSPLY SIRONA had a positive return on equity of 7.13% and a negative net margin of 1.40%. The company’s quarterly revenue was down 51.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.66 EPS. As a group, equities analysts predict that DENTSPLY SIRONA will post 1.1 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 9th. Shareholders of record on Friday, September 25th will be given a $0.10 dividend. The ex-dividend date of this dividend is Thursday, September 24th. This represents a $0.40 annualized dividend and a yield of 0.84%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 16.33%.
Institutional investors have recently bought and sold shares of the business. M&T Bank Corp boosted its stake in shares of DENTSPLY SIRONA by 2.0% during the 2nd quarter. M&T Bank Corp now owns 14,357 shares of the medical instruments supplier’s stock valued at $634,000 after buying an additional 277 shares during the period. Signaturefd LLC raised its holdings in DENTSPLY SIRONA by 49.8% in the 2nd quarter. Signaturefd LLC now owns 933 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 310 shares during the period. CSat Investment Advisory L.P. increased its holdings in shares of DENTSPLY SIRONA by 39.2% during the 1st quarter. CSat Investment Advisory L.P. now owns 1,179 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 332 shares during the period. Blair William & Co. IL increased its holdings in shares of DENTSPLY SIRONA by 1.6% during the 1st quarter. Blair William & Co. IL now owns 24,077 shares of the medical instruments supplier’s stock worth $935,000 after purchasing an additional 378 shares during the period. Finally, Cigna Investments Inc. New increased its holdings in shares of DENTSPLY SIRONA by 6.6% during the 1st quarter. Cigna Investments Inc. New now owns 6,300 shares of the medical instruments supplier’s stock worth $245,000 after purchasing an additional 390 shares during the period. Hedge funds and other institutional investors own 96.00% of the company’s stock.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Further Reading: How to find the components of the quick ratio
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.